• / Free eNewsletters & Magazine
  • / My Account
Home>Paul Larson

Paul Larson

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. Our Take on the Second Quarter

    Stocks eked out gains amid Fed-watching, continued mergers and acquisitions, and the ongoing Greek debt crisis.

  2. Union Pacific: A Good Bet for the Long Haul

    Coal headwinds should only be temporary for wide-moat Union Pacific, which gives it an advantage over other rail companies, says Morningstar's Matt Coffina.

  3. 3 Ways to Use Market Valuation Data

    Learn whether the market is cheap or expensive--and what you can do about it.

  4. Larson's Strategies for Excess Returns

    StockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.

  5. How to Protect From Black Swans and Black Boxes

    The financial crisis proved that tumultuous events can and do happen, and investors need to keep a long-term perspective in a market that is incredibly short-term focused, says StockInvestor editor Paul Larson .

  6. A Rare Time for Wide-Moat Stocks?

    StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks.

  7. 4 Companies Leading the Next Wave of Cancer-Drug Innovation

    First movers and firms that provide combination therapies represent the best investment opportunities in the immuno-oncology market, says Morningstar's Damien Conover.

  8. New Wide Moats in Banks and Software

    We recently upgraded a few banks and enterprise software firms to wide moat status, and raised our fair value estimates on health-care REITs.

  9. MLPs: High-Quality Income Generators

    Tax advantages and economic moats allow master limited partnerships to offer investors much more than just high yields, says Morningstar's Paul Larson .

  10. New Year, New Moat Ratings for These Stocks

    Competitive advantages improved for one health-care firm, while a spin-off at another narrowed its moat, says Morningstar's Paul Larson in his discussion on recent moat-rating upgrades and downgrades.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.